| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Fu Wei | Director | C/O NOVABRIDGE BIOSCIENCES,, 2440 RESEARCH BOULEVARD, SUITE 400, ROCKVILLE | /s/ Xi-Yong (Sean) Fu as attorney-in-fact | 18 Mar 2026 | 0001885756 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | NBP | Ordinary Shares | 11,784,164 | 18 Mar 2026 | By CBC Investment l-Mab Limited | F1, F2, F3 | |||||
| holding | NBP | Ordinary Shares | 3,641,544 | 18 Mar 2026 | By IBC Investment Seven Limited | F1, F4, F5 | |||||
| holding | NBP | Ordinary Shares | 5,574,560 | 18 Mar 2026 | By CBC SPVII Limited | F1, F6, F7 | |||||
| holding | NBP | Ordinary Shares | 2,369,546 | 18 Mar 2026 | By C-Bridge II Investment Ten Limited | F1, F8, F9 | |||||
| holding | NBP | Ordinary Shares | 7,129,885 | 18 Mar 2026 | By Nova Aqua Limited | F1, F10, F11 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | NBP | 2025 Employee Share Option (right to buy) | 18 Mar 2026 | Ordinary Shares | 1,635,729 | $3.19 | Direct | F1, F12, F13 | ||||||
| holding | NBP | 2025 Employee Share Option (right to buy) | 18 Mar 2026 | Ordinary Shares | 2,453,583 | $3.19 | Direct | F1, F12, F14 | ||||||
| holding | NBP | 2025 Employee Share Option (right to buy) | 18 Mar 2026 | Ordinary Shares | 2,453,583 | $3.19 | Direct | F1, F12, F15 |
| Id | Content |
|---|---|
| F1 | The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer. |
| F2 | Reported securities are represented by 5,123,549 ADSs. |
| F3 | CBC Investment l-Mab Limited ("CBC:) is controlled by C-Bridge Healthcare Fund II, L.P. ("C-Bridge Healthcare"), C-Bridge Healthcare Fund GP II, L.P. ("C-Bridge Healthcare GP") is the general partner of C-Bridge Healthcare, C-Bridge Capital GP, Ltd. ("C-Bridge Capital") is the general partner of C-Bridge Healthcare GP and the Reporting Person may be deemed to control C-Bridge Capital. The Reporting Person disclaims beneficial ownership of the securities held directly by CBC except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
| F4 | Reported securities are represented by 1,583,284 ADSs. |
| F5 | IBC Investment Seven Limited ("IBC") is controlled by l-Bridge Healthcare Fund, L.P. ("I-Bridge"), l-Bridge Healthcare GP, L.P. ("I-Bridge GP") is the general partner of I-Bridge, C-Bridge Capital is the general partner of I-Bridge GP and the Reporting Person may be deemed to control C-Bridge Capital. The Reporting Person disclaims beneficial ownership of the securities held directly by IBC except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
| F6 | Reported securities are represented by 2,423,721 ADSs. |
| F7 | CBC SPVII Limited ("CBC SPVII") is controlled by I-Bridge, I-Bridge GP is the general partner of I-Bridge, C-Bridge Capital is the general partner of I-Bridge GP and the Reporting Person may be deemed to control C-Bridge Capital. The Reporting Person disclaims beneficial ownership of the securities held directly by CBC SPVII except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
| F8 | Reported securities are represented by 1,030,237 ADSs. |
| F9 | C-Bridge II Investment Ten Limited ("C-Bridge") is controlled by C-Bridge Healthcare, C-Bridge Healthcare GP is the general partner of C-Bridge Healthcare, C-Bridge Capital is the general partner of C-Bridge Healthcare GP and the Reporting Person may be deemed to control C-Bridge Capital. The Reporting Person disclaims beneficial ownership of the securities held directly by C-Bridge except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
| F10 | Reported securities are represented by 3,099,950 ADSs. |
| F11 | The securities are held through a trust which was established by the Reporting Person (as the settlor) for the benefit of the Reporting Person and his family. The Reporting Person disclaims beneficial ownership of these except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose |
| F12 | Number of underlying securities and exercise price expressed in terms of ADSs. |
| F13 | The option vests, if at all, in eight equal quarterly installments following the date on which the 30-trading-day weighted average price of the Issuer's ADS (based on trading days only) is at or above US$8.00. |
| F14 | The option vests, if at all, in eight equal quarterly installments following the date on which the 30-trading-day weighted average price of the Issuer's ADS (based on trading days only) is at or above US$12.00. |
| F15 | The option vests, if at all, in eight equal quarterly installments following the date on which the 30-trading-day weighted average price of the Issuer's ADS (based on trading days only) is at or above US$16.00. |
Exhibit List: Ex. 24.1 - Power of Attorney